Loomis Sayles & Co. L P Has $39.10 Million Stake in Teladoc Health Inc (TDOC)

Loomis Sayles & Co. L P reduced its stake in Teladoc Health Inc (NYSE:TDOC) by 24.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 452,814 shares of the health services provider’s stock after selling 145,799 shares during the period. Loomis Sayles & Co. L P’s holdings in Teladoc Health were worth $39,100,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in the company. Axiom International Investors LLC DE lifted its holdings in Teladoc Health by 7.0% during the 3rd quarter. Axiom International Investors LLC DE now owns 90,080 shares of the health services provider’s stock worth $7,778,000 after buying an additional 5,890 shares in the last quarter. Baillie Gifford & Co. lifted its holdings in Teladoc Health by 14.0% during the 3rd quarter. Baillie Gifford & Co. now owns 699,827 shares of the health services provider’s stock worth $60,430,000 after buying an additional 86,183 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Teladoc Health by 47.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 47,400 shares of the health services provider’s stock worth $4,093,000 after buying an additional 15,300 shares in the last quarter. Hsbc Holdings PLC acquired a new position in Teladoc Health during the 3rd quarter worth $3,322,000. Finally, Blair William & Co. IL lifted its holdings in Teladoc Health by 13.2% during the 3rd quarter. Blair William & Co. IL now owns 48,480 shares of the health services provider’s stock worth $4,186,000 after buying an additional 5,662 shares in the last quarter.

TDOC has been the topic of several research reports. KeyCorp upped their price objective on Teladoc Health from $74.00 to $90.00 and gave the stock an “overweight” rating in a report on Monday, August 27th. MED upped their price objective on Teladoc Health from $68.00 to $89.00 and gave the stock an “outperform” rating in a report on Friday, September 28th. Citigroup upped their price objective on Teladoc Health from $80.00 to $88.00 and gave the stock a “buy” rating in a report on Friday, September 21st. Jefferies Financial Group set a $90.00 price objective on Teladoc Health and gave the stock a “buy” rating in a report on Friday, September 28th. Finally, Craig Hallum upped their price objective on Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, October 15th. Four analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Teladoc Health presently has a consensus rating of “Buy” and an average target price of $85.06.

TDOC opened at $64.88 on Tuesday. The company has a quick ratio of 8.99, a current ratio of 8.99 and a debt-to-equity ratio of 0.40. Teladoc Health Inc has a 12 month low of $30.85 and a 12 month high of $89.05.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Thursday, November 1st. The health services provider reported ($0.34) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.36) by $0.02. Teladoc Health had a negative net margin of 31.32% and a negative return on equity of 14.05%. The business had revenue of $111.00 million during the quarter, compared to analysts’ expectations of $109.94 million. During the same quarter in the prior year, the company earned ($0.55) EPS. The firm’s quarterly revenue was up 61.6% on a year-over-year basis. On average, analysts anticipate that Teladoc Health Inc will post -1.47 EPS for the current year.

In other Teladoc Health news, CEO Jason N. Gorevic sold 35,000 shares of the stock in a transaction dated Monday, November 19th. The stock was sold at an average price of $54.80, for a total transaction of $1,918,000.00. Following the completion of the transaction, the chief executive officer now owns 541,184 shares in the company, valued at approximately $29,656,883.20. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, President Peter A. Mcclennen sold 69,224 shares of the stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $66.77, for a total value of $4,622,086.48. Following the transaction, the president now owns 12,692 shares of the company’s stock, valued at approximately $847,444.84. The disclosure for this sale can be found here. In the last 90 days, insiders sold 237,727 shares of company stock valued at $16,507,946. 3.95% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Loomis Sayles & Co. L P Has $39.10 Million Stake in Teladoc Health Inc (TDOC)” was posted by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.com-unik.info/2018/12/04/loomis-sayles-co-l-p-has-39-10-million-stake-in-teladoc-health-inc-tdoc.html.

Teladoc Health Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Read More: Short Selling Stocks and Day Traders

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit